In this study, we demostrate that a recently reported small molecule inhibitor of the canonical Wnt pathway, SEN461 [34], results in Axin1 stabilization followed by decreased total β-catenin levels in the osteosarcoma cell lines. This evidence concerns the gene AXIN1 and osteosarcoma.